Uulke A. van der Heide1, Catalina Arteaga de Castro1, Greetje Groenendaal1, Cornelis A.T. van den Berg1, Ina M. Jurgenliemk-Schulz1, Judith M. Roesink1
1Radiotherapy, UMC Utrecht, Utrecht, Netherlands
Dynamic contrast-enhanced MRI was used to monitor cervical tumors prior to and in the first four weeks of chemoradiation. An increase in Ktrans was observed in the first four weeks. Also Ktrans in the poorest perfused part of the tumor seems indicative for the rate of tumor regression.